Anti-Neoplastic Agents Market Research Report Information, by type (alkylating and alkylating-like agents, antimetabolites, antitumor antibiotics, plant alkaloids, hormonal agents, and miscellaneous agents), by end user (hospitals, clinics, research institutes, cancer rehabilitation centers and others) - Forecast to 2032

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Anti-Neoplastic Agents Market, by Type

5.1 Introduction

5.1.1 Alkylating and Alkylating-like Agents

5.1.2 Antimetabolites

5.1.3 Antitumor Antibiotics

5.1.4 Plant Alkaloids

5.1.5 Hormonal Agents

5.1.6 Miscellaneous Agents

6 Global Anti-Neoplastic Agents Market, by End User

6.1 Introduction

6.1.1 Hospitals

6.1.2 Clinics

6.1.3 Research Institutes

6.1.4 Cancer Rehabilitation Centers

6.1.5 Others

7 Global Anti-Neoplastic Agents Market, by Regions

7.1 Introduction

7.1.1 Americas

7.1.1.1 North America

7.1.1.2 South America

7.1.2 Europe

7.1.2.1 Germany

7.1.2.2 France

7.1.2.3 UK

7.1.2.4 Italy

7.1.2.5 Spain

7.1.2.6 Rest of Europe

7.1.3 Asia Pacific

7.1.3.1 Japan

7.1.3.2 China

7.1.3.3 India

7.1.3.4 Republic of Korea

7.1.3.5 Rest of Asia Pacific

7.1.4 Middle East & Africa

8 Company Landscape

8.1 Introduction

8.1.1 Mergers Acquisitions

8.1.2 Collaborations

8.1.3 Release/New Product Launches

8.1.4 Other (Expansion, Updates, Partnership)

9 Company Profile

9.1 AbbVie Inc.

9.1.1 Company Overview

9.1.2 Product/Business Segment Overview

9.1.3 Financials

9.1.4 Key Developments

9.1.5 SWOT Analysis

9.2 Amgen Inc.

9.2.1 Overview

9.2.2 Product/Business Segment Overview

9.2.3 Financials

9.2.4 Key Developments

9.2.5 SWOT Analysis

9.3 Aspen Holdings

9.3.1 Overview

9.3.2 Product/Business Segment Overview

9.3.3 Financials

9.3.4 Key Developments

9.3.5 SWOT Analysis

9.4 Baxter Healthcare Corporation

9.4.1 Overview

9.4.2 Product/Business Segment Overview

9.4.3 Financials

9.4.4 Key Developments

9.4.5 SWOT Analysis

9.5 Bayer AG

9.5.1 Overview

9.5.2 Product/Business Segment Overview

9.5.3 Financials

9.5.4 Key Developments

9.5.5 SWOT Analysis

9.6 Boehringer Ingelheim GmbH

9.6.1 Overview

9.6.2 Product/Business Segment Overview

9.6.3 Financials

9.6.4 Key Developments

9.6.5 SWOT Analysis

9.7 Bristol-Myers Squibb Company

9.7.1 Overview

9.7.2 Product/Business Segment Overview

9.7.3 Financials

9.7.4 Key Developments

9.7.5 SWOT Analysis

9.8 F. Hoffmann-La Roche Ltd

9.8.1 Overview

9.8.2 Product/Business Segment Overview

9.8.3 Financials

9.8.4 Key Developments

9.8.5 SWOT Analysis

9.9 Genentech Inc.

9.9.1 Overview

9.9.2 Product/Business Segment Overview

9.9.3 Financials

9.9.4 Key Developments

9.9.5 SWOT Analysis

9.10 Pfizer Inc.

9.10.1 Overview

9.10.2 Product/Business Segment Overview

9.10.3 Financials

9.10.4 Key Developments

9.10.5 SWOT Analysis

9.11 Teva pharmaceutical Industries Ltd

9.11.1 Overview

9.11.2 Product/Business Segment Overview

9.11.3 Financials

9.11.4 Key Developments

9.11. SWOT Analysis

9.12 Others

10 Appendix

List of Tables

TABLE 1 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, 2020-2027 (USD MILLION)

TABLE 2 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY REGION, 2020-2027 (USD MILLION)

List of Figures

FIGURE 1 RESEARCH PROCESS

FIGURE 2 PORTERS FIVE FORCES MODEL

FIGURE 3 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY TYPE

FIGURE 4 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY END USER

FIGURE 5 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY REGION

FIGURE 6 GLOBAL ANTI-NEOPLASTIC AGENTS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)